Hisashi Tachizaki, Canon’s current senior VP and chief marketing executive. #RSNA22 He will be heading the U.S. based company as its president and CEO.

“The U.S. market is more and more important for our business,” the company's president and CEO said during a press conference at RSNA 2022. 

Women with dense breasts and benign breast disease have increased risks of developing #breastcancer

JoAnn Pushkin, breast cancer survivor and executive director of DenseBreast-info.org, sounded the alarm on the lack of awareness surrounding breast density and its associated cancer risks during a presentation at this year’s annual RSNA meeting.

The use of NSAIDS such as ibuprofen and naproxen might not have the desired effect patients are seeking when it comes to joint pain, according to new findings to be presented at RSNA 2022. 

The clinical application of scatter correction software is limited by numerous factors, according to a new analysis.

Around the web

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

"I see, at least for the next decade, this being a SPECT and PET world, not one or the other," explained Tim Bateman, MD.

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab.